Abbott Laboratories (ABT) Social Stream
ABBOTT LABORATORIES (ABT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ABBOTT LABORATORIES.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-27 | 14 | $146 | $125 | $137.166 | $110.98 | 23.6% |
| 2021-12-10 | 15 | $146 | $125 | $137.846 | $110.98 | 24.21% |
| 2021-12-22 | 14 | $150 | $125 | $138.583 | $110.98 | 24.87% |
| 2022-01-24 | 14 | $157 | $125 | $140.333 | $110.98 | 26.45% |
| 2022-01-27 | 13 | $151 | $125 | $139.25 | $110.98 | 25.47% |
| 2022-04-11 | 14 | $151 | $125 | $139.307 | $110.98 | 25.52% |
| 2022-04-14 | 14 | $151 | $125 | $140.461 | $110.98 | 26.56% |
| 2022-05-18 | 10 | $151 | $125 | $141.181 | $110.98 | 27.21% |
| 2022-06-07 | 10 | $150 | $125 | $140.636 | $110.98 | 26.72% |
| 2022-06-13 | 10 | $150 | $125 | $139.727 | $110.98 | 25.9% |
| 2022-07-22 | 12 | $150 | $95 | $127.083 | $110.98 | 14.51% |
| 2022-09-28 | 13 | $150 | $95 | $127.153 | $110.98 | 14.57% |
| 2022-10-05 | 13 | $150 | $95 | $126.692 | $110.98 | 14.16% |
| 2022-10-11 | 15 | $144 | $95 | $125.461 | $110.98 | 13.05% |
| 2022-10-12 | 15 | $144 | $95 | $124.357 | $110.98 | 12.05% |
| 2022-10-18 | 15 | $144 | $95 | $124.142 | $110.98 | 11.86% |
| 2022-10-21 | 16 | $144 | $95 | $122.333 | $110.98 | 10.23% |
| 2022-12-05 | 16 | $140 | $95 | $117.466 | $110.98 | 5.84% |
| 2022-12-12 | 16 | $140 | $95 | $118 | $110.98 | 6.33% |
| 2023-01-04 | 16 | $140 | $95 | $118.533 | $110.98 | 6.81% |
| 2023-01-06 | 16 | $140 | $95 | $119.6 | $110.98 | 7.77% |
| 2023-01-23 | 15 | $140 | $95 | $119.6 | $110.98 | 7.77% |
| 2023-01-25 | 15 | $140 | $95 | $119.933 | $110.98 | 8.07% |
| 2023-01-27 | 16 | $140 | $95 | $122.333 | $110.98 | 10.23% |
| 2023-03-28 | 16 | $140 | $95 | $122.533 | $110.98 | 10.41% |
| 2023-04-05 | 16 | $140 | $95 | $121.866 | $110.98 | 9.81% |
| 2023-04-17 | 16 | $136 | $95 | $121.6 | $110.98 | 9.57% |
| 2023-04-20 | 18 | $136 | $103 | $123.733 | $110.98 | 11.49% |
| 2023-05-16 | 18 | $136 | $103 | $124.437 | $110.98 | 12.13% |
| 2023-07-13 | 18 | $136 | $103 | $123.125 | $110.98 | 10.94% |
| 2023-07-21 | 18 | $136 | $103 | $123.125 | $110.98 | 10.94% |
| 2023-07-24 | 18 | $136 | $103 | $123.75 | $110.98 | 11.51% |
| 2023-09-08 | 18 | $136 | $103 | $123.875 | $110.98 | 11.62% |
| 2023-10-02 | 18 | $136 | $103 | $123.375 | $110.98 | 11.17% |
| 2023-10-10 | 18 | $136 | $103 | $122.937 | $110.98 | 10.77% |
| 2023-10-17 | 18 | $136 | $103 | $122.312 | $110.98 | 10.21% |
| 2023-10-19 | 18 | $136 | $103 | $120.375 | $110.98 | 8.47% |
| 2023-12-06 | 18 | $133 | $103 | $118.687 | $110.98 | 6.94% |
| 2023-12-13 | 18 | $133 | $103 | $119 | $110.98 | 7.23% |
| 2023-12-21 | 18 | $133 | $103 | $119.625 | $110.98 | 7.79% |
The Trend in the Analyst Price Target
Over the past 21 months, ABT's average price target has gone down $20.84.
ABT reports an average of 16.01% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 16 | 140 | 95 | 122.333 | 109.95 | 11.26% |
| 2023-05-16 | 18 | 136 | 103 | 124.437 | 109.39 | 13.76% |
| 2023-05-30 | 18 | 136 | 103 | 123.125 | 101.71 | 21.05% |
| 2023-07-24 | 18 | 136 | 103 | 123.750 | 114.62 | 7.97% |
| 2023-12-13 | 18 | 133 | 103 | 119.000 | 107.25 | 10.96% |
ABT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.56 | 12 | 2 | 4 | 0 | 0 | 18 |
The Trend in the Broker Recommendations
ABT's average broker recommendation rating improved by 0.28 over the prior 30 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ABBOTT LABORATORIES's average analyst price target is higher than 4870.11% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ABBOTT LABORATORIES's number of analysts covering the stock is greater than 4798.48% of them.
- ABT has a lower variance in analysts' estimates than -784.16% of Pharmaceutical Products stocks.
- ABT has a higher upside potential (average analyst target price relative to current price) than 1098.22% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ABBOTT LABORATORIES are BNTX, MRNA, and GILD.
View All Top Stocks by Price Target
Make investment decisions regarding ABT using the data that counts. Try POWR Ratings for free.